Labcorp Holdings Inc. (LON:0JSY)
London flag London · Delayed Price · Currency is GBP · Price in USD
249.15
+2.97 (1.21%)
At close: Jun 3, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Diagnostics (Dx)
10.29B
Log In
Log In
Log In
Log In
Upgrade
Diagnostics (Dx) Growth
8.22%
Log In
Log In
Log In
Log In
Upgrade
Biopharma Laboratory Services (BLS)
2.93B
Log In
Log In
Log In
Log In
Upgrade
Biopharma Laboratory Services (BLS) Growth
3.87%
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 2013 - 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2013 - 2020
Diagnostics (Dx) Operating Earnings
1.62B
Log In
Log In
Log In
Log In
Upgrade
Diagnostics (Dx) Operating Earnings Growth
3.07%
Log In
Log In
Log In
Log In
Upgrade
Biopharma Laboratory Services (BLS) Operating Earnings
466.00M
Log In
Log In
Log In
Log In
Upgrade
Biopharma Laboratory Services (BLS) Operating Earnings Growth
10.30%
Log In
Log In
Log In
Log In
Upgrade

Other

Fiscal year is January - December.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 2012 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2019
Organic Revenue Growth
Log In
Log In
Log In
Log In
Upgrade
North America % Total Revenue
Log In
Log In
Log In
Log In
Upgrade
North America % Total Revenue Growth
Log In
Log In
Log In
Log In
Upgrade
Europe % Total Revenue
Log In
Log In
Log In
Log In
Upgrade
Europe % Total Revenue Growth
Log In
Log In
Log In
Log In
Upgrade
Other Geography % Total Revenue
Log In
Log In
Log In
Log In
Upgrade
Other Geography % Total Revenue Growth
Log In
Log In
Log In
Log In
Upgrade